Day Zero - CEO Forum Day (April 28),
Business Design Centre, London, UK
Navigate Biotech Financing: Secure Capital and Partnerships
Come to where biotech leaders meet.
Industry insights, trends, best practices & benchmarking.
Meet the right people through one-to-one meetings.
"LSX has evolved into a trusted partnership which helps us connect with innovative and exciting life science companies"
- Senior Director-Business Development Strategic Operations and Intelligence, Lilly
Biotech Leaders is part of LSX World
For the last 10 years, we’ve connected Biotech Leaders with the capital, advisors, and strategic partners to help them take their innovation from concept to market.
At the core of our community are the brilliant minds driving innovation:
- Trailblazing Entrepreneurs: Founders and CEOs of the most innovative drug discovery and therapeutic startups and SMEs
- Visionary Investors: Leading health and life science investors from Europe and the USA
- Industry Giants: Pharmaceutical companies seeking fresh ideas, new partnerships, and expert advisors
Together, we’re creating the medicines of the future.
3 focused tracks
CAPITAL MARKETS & INVESTMENT
Gain access to expert insights from some of the industry’s top investors to navigate the shifting biotech financing landscape.
PARTNERSHIPS & DEAL MAKING
Keep up to date with pharma partnering strategies and key therapeutic areas of interest to stay ahead of the competition amidst the looming patent cliff.
SCALING & COMMERCIALISATION
Look no further to find experienced biotech executives and leaders who have been there, done that, and have the battle scars to prove it.
Meet our 2025 Biotech Speakers
5 Reasons to choose Biotech Leaders
- Biotech Leaders is Europe’s largest and most significant Biotech CEO gathering. No other event is exclusively designed to address all the strategic and partnering goals of Europe’s Biotech CEO ecosystem.
- Biotech Leaders attracts the highest quality speakers from the biggest and best large pharma and life science investment firms. Hear from global BD heads at GSK, Eli Lilly, Merck KGaA, Novartis, Novo Nordisk and top tier investment funds like Abingworth, Forbion, Sofinnova and SV Health Investors.
- No other event offers access to as many highly-qualified, specialist life science investors. Bringing over 400 of the world’s most active investors to London. Fundraising? There’s no better place to be.
- All biotechs, investors and pharma attendees are qualified during the registration process to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.
- As well as partnering, content, showcases and exhibition, Biotech Leaders offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.
Snapshot of our 2025 companies
